-
-
Statins Personalized Medication solutions
Considering the close correlation between the ApoE and SLCO1B1 genetic polymorphisms and therapeutic efficacy and adverse effects of drugs between individuals, Tianlong Personalized Medication
Solution is designed to rapidly determine the genetic polymorphism of the most common variants in these two genes, including ApoE (c.388 T>C), ApoE (c.526 C>T), SLCO1B1 (c.388 A>G) and SLCO1B1(c.521 T>C)in specimen with its exclusive pharmacogenomic reagents and the Fascan 48E multi-channel fluorescence quantitative analyzer. The results can provide genetic clues to guide rational drug selection or dosages and to reduce adverse drug reactions for statins in clinical practices.
-
| Product name | Specification | Specimen | Target gene loci |
LigSeg Reagent Kit (SNP-U4) | 20 T/Kit | 2 mL of EDTA anticoagulated whole blood | ApoE(C.388 T＞C) ApoE(C.526 C＞T) SLCO1B1(C.388 A＞G) SLCO1B1(C.521 T＞C) |
| LigSeg Reagent Kit (SNP-U3) | |
|---|---|
| Specification | 20 T/Kit |
| Specimen | 2 mL of EDTA anticoagulated whole blood |
| Target gene loci | ApoE(C.388 T＞C) ApoE(C.526 C＞T) SLCO1B1(C.388 A＞G) SLCO1B1(C.521 T＞C) |
Contact us